We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Researchers Validate In Vivo Imaging Research Method for Studying Drug Efficiency and Disease Progression

Read time: Less than a minute

In a paper published in the online edition of the Journal of Molecular Imaging and Biology (DOI 10.1007/s11307-006-0058-z, 10/12/2006), a team of Mayo Clinic researchers led by Stephanie Carlson, M.D., reported that combined MicroSPECT and micro CT imaging can be used to quantify intratumoral radioisotope uptake in vivo and is more reliable than planar or MicroSPECT imaging alone.

The research team carried out the study using a dual modality MicroSPECT/micro CT in vivo imaging system from Gamma Medica-Ideas.

Using in vivo imaging to collect quantitation data can save drug development and research time and improve the accuracy of pre-clinical research.